Radiation Therapy on the Objective Response and Outcomes with Nivolumab for Hepatocellular Carcinoma

Radiation Therapy on the Objective Response and Outcomes with Nivolumab for Hepatocellular Carcinoma

Mount Sinai Health System

4 months
52 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
Report 0 0
Category:
Description:

William Smith, MD of Mount Sinai describes the effect of radiation therapy on the objective response and outcomes with nivolumab for hepatocellular carcinoma.

________

Among patients with unresectable hepatocellular carcinoma who received combination upfront RT and nivolumab, we found the objective response rate (as determined by mRECIST criteria) to be 35%, substantially increased from historical controls, suggesting that this approach may increase the proportion of patients that would benefit from immune checkpoint inhibition.

Up Next Autoplay